PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,340 | -23.4% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $20,035 | -1.8% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $20,405 | +5.7% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $19,305 | -28.5% | 500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $27,000 | -6.9% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -23.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $38,000 | +26.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $30,000 | +7.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $28,000 | -6.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $30,000 | -14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | +16.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $30,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | +15.4% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | +52.9% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $17,000 | -26.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $23,000 | +21.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $19,000 | -13.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | +15.8% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $19,000 | -91.1% | 500 | -77.3% | 0.00% | -88.9% |
| Q3 2014 | $213,000 | – | 2,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |